Author:
Fukumoto Atsushi,Kim Yong-Pil,Matsumoto Atsuko,Takahashi Yoko,Suzuki Makoto,Onodera Hideyuki,Tomoda Hiroshi,Matsui Hidehito,Hanaki Hideaki,Iwatsuki Masato,Ōmura Satoshi,Shiomi Kazuro
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference25 articles.
1. Diep, B. A. & Otto, M. The role of virulence determinants in community-associated MRSA pathogenesis. Trends Microbiol. 16, 361–369 (2008).
2. Iwatsuki, M. et al. Biverlactones A-D, new circumventors of arbekacin resistance in MRSA, produced by Penicillium sp. FKI-4429. Tetrahedron 67, 6644–6648 (2011).
3. Fukumoto, A. et al. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. I. Taxonomy, fermentation, isolation and structural elucidation. J. Antibiot. 61, 1–6 (2008).
4. Fukumoto, A. et al. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities. J. Antibiot. 61, 7–10 (2008).
5. Omura, S. et al. (Kitasato Institute, Japan; Kyowa Hakko Kirin Co., Ltd., Japan). KB-3346-5 substances, their fermentative manufacture, and antibacterial agents containing them. Jpn. Kokai Tokkyo Koho, JP2009046404A (2009).
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献